Eisai Announces U.S. Fda Approval For New Higher Dose Aricept® 23 Mg Tablet For The Treatment Of Moderate-To-Severe Alzheimer's Disease
Links shared publicly online about this topic.
- 982total visits
Eisai Announces U.S. Fda Approval For New Higher Dose Aricept® 23 Mg Tablet For The Treatment Of Moderate-To-Severe Alzheimer's Disease
View full resource at medicalnewstoday.com
Tags: Alzheimer's Disease, Alzheimer's Disease Medication, Disease and Condition, Drug, FDA, Aricept, Eisai
Most Recently Shared on July 31, 2010 at 3:05 pm By:
Eisai Announces U.S. Fda Approval For New Higher Dose Aricept® 23 Mg Tablet For The Treatment Of Moderate-To-Sever... http://mnt.to/3GPp
Also Shared By:
Eisai Inc. and Pfizer Inc Announce U.S. FDA Approval for New Higher-Dose Aricept (donepezil HCl) 23 mg Tablet for the Treatment of Moderate-to-Severe Alzheimer's Disease
drugs.com — “Aricept (donepezil) is used to treat Alzheimer's disease. Includes Aricept side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on July 27, 2010 at 2:15 am By:
FDA Approves Higher-Dose Aricept (donepezil) 23 mg for the Treatment of Alzheimer's Disease - http://bit.ly/9TBLyE
FDA approves Aricept 23 mg tablet for Alzheimer's disease
news-medical.net — “Eisai Inc. and Pfizer Inc announced today that the U.S. Food and Drug Administration (FDA) approved a new once-daily, higher-dose Aricept 23 mg tablet for the treatment of moderate-to-severe Alzheimer's disease (AD). Aricept 23 mg tablet offers another dosing option for patients with moderate-to-severe AD, for whom few treatments are available” View full resource at news-medical.net
Most Recently Shared on July 26, 2010 at 6:48 am By:
Oncology News: FDA approves Aricept 23 mg tablet for Alzheimer's disease: Eisai Inc. and Pfizer Inc announced toda... http://bit.ly/bUsCXG
Advertisement



MNT Alzheimer's News
@mnt_alzheimers
Eisai Announces U.S. Fda Approval For New Higher Dose Aricept® 23 Mg Tablet For The Treatment Of Moderate-To-Sever... http://mnt.to/3GPp
1 year ago...